Objectives This study evaluated the impact of clinical and physiological factors limiting
treatment optimization toward recommended medical therapy in heart failure (HF) …

Abstract Over the last 15–20 years, remarkable developments of heart failure (HF)
pharmacotherapies have been achieved. However, HF remains a global healthcare …

Aims To evaluate how recommendations of European guidelines regarding
pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in …

Objectives: This study investigated adherence to drug therapy guidelines in heart failure
(HF) with reduced left-ventricular ejection fraction (LVEF) of< 40%(heart failure with reduced …

Aims In symptomatic patients with heart failure and reduced ejection fraction (HFrEF), recent
international guidelines recommend initiating four major therapeutic classes rather than …

Heart failure (HF) with reduced ejection fraction (HFrEF) is a common and costly condition
that diminishes patients' health status and confers a poor prognosis. Despite the availability …

The Heart Failure Adherence and Retention Trial (HART) provided an opportunity to
determine adherence to evidence‐based guidelines (EBG) in patients with heart failure …

Background Physicians' adherence to guideline‐recommended therapy is associated with
short‐term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF) …

Recommendations represent the core messages of guidelines, and are particularly
important when the body of scientific evidence is rapidly growing, as in the case of heart …

Aims Data from patient registries give insight into the management of patients with heart
failure (HF), but actual data from unselected real-world HF patients are scarce. Therefore …